| 1/3 | US=12 / Dermatologia Schwartzentruber DJ, Rosenberg SA. Interleukins. In: Balch CM, Houghton NA, Sober AJ, Soong S. Cutaneous melanoma. 4ªed. St. Louis: Quality Medical Publishing, 2003. p. 623-43. INTERLEUKIN-2; FARMACOLOGIA DE INTERLEUKIN-2; TOXICIDADE E AGENTES DE REDUCAO; MELANOMA METASTATICA |
| 2/3 | US=11-B / Quimioterapia Ozer H, Kurkjian C. Biologic response modifiers: principles of biotherapy. In: Perry MC. The chemotherapy source book. 4th ed. Philadelphia: Wolters Kluwer, 2008. p. 53-64. ISBN 978-0-7817-7328-7. MODIFICADORES DA RESPOSTA BIOLOGICA; BIOTERAPIA; INTERFERON; LEUCEMIA MIELOGENA CRONICA; LEUCEMIA DE CELULAS PILOSAS; CARCINOMA DE CELULAS RENAIS; MELANOMA; INTERLEUKIN-2; FATOR DE NECROSE TUMORAL; ANTICORPOS MONOCLONAIS; RITUXIMABE; TRASTUZUMABE; GEMTUZUMAB OZOGAMICINA; ALEMTUZUMAB; CETUXIMABE; BEVACIZUMABE |
| 3/3 | US=110 / Câncer Robinson-Bostom L, Kawaoka J, Rupani R, McDonald CJ. Alopecia and cutaneous complications. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 625-40. ISBN 978-0-443-06695-5. CANCER; ALOPECIA; COMPLICACOES CUTANEAS; CELULITE; FLEBITE; DISESTESIA PALMAR-PLANTAR; ERITRODISESTESIA; ERITEMA ACRAL; HIPERPIGMENTACAO; ALTERACOES NAS UNHAS; DERMATITE; HIDRADENITE ECRINA NEUTROFILICA; METAPLASIA SIRINGOESCAMOSA; MODIFICADORES DE RESPOSTA BIOLOGICA; REACAO CUTANEA; INTERLEUKIN-2; INIBIDORES PROTEOSSOMICOS |